Breaking Research News from Breastcancer.org
Comments
-
Long-Term Exposure to Fine-Particle Air Pollution Increases Breast Cancer Risk
Oct 30, 2023
Living and working in places with high levels of a specific type of air pollution increases breast cancer risk. Read more…
0 -
Long-Term Benefits of Verzenio for Early-Stage Breast Cancer Confirmed
Oct 30, 2023
Five years of follow-up show Verzenio continues to reduce early-stage breast cancer recurrence risk long after people stop taking it. Read more…
0 -
Short-Term Fasting Improves Quality of Life During Chemotherapy
Oct 30, 2023
“The short-term fasting group didn’t even develop any clinically visible fatigue,” according to the study presenter. Read more…
0 -
Dato-DXd Seems Promising As New Treatment for Certain Metastatic Breast Cancers
Nov 1, 2023
The experimental medicine Dato-DXd may be a new treatment option for certain metastatic, hormone receptor-positive breast cancers. Read more…
0 -
FDA Approves Truqap for Certain Metastatic, Hormone Receptor-Positive Breast Cancers
Nov 17, 2023
Truqap is a new targeted therapy option for metastatic, hormone receptor-positive breast cancer with specific genetic mutations that has stopped responding to other hormonal therapy medicines. Read more…
0 -
Long-Term Results Confirm Benefits of Ovarian Suppression With Tamoxifen
Nov 21, 2023
Ovarian suppression plus tamoxifen lowers recurrence risk. Read more…
0 -
Lymph Node Surgery Not Needed for Certain Small Breast Cancers
Nov 21, 2023
If you’re diagnosed with a small breast cancer, you can likely skip lymph node surgery. Read more…
0 -
Vaginal Estrogen Safe for Women With Breast Cancer
Nov 21, 2023
Women with breast cancer can safely use vaginal estrogen to treat certain menopausal symptoms. Read more…
0 -
Obesity Ups Recurrence Risk in Women Treated With Aromatase Inhibitors
Nov 24, 2023
The risk of breast cancer recurrence is higher in women with obesity treated with an aromatase inhibitor. Read more…
0 -
Chemotherapy Before Surgery May Mean Lymph Node Radiation Not Needed
Dec 5, 2023
If chemotherapy before surgery destroys cancer in the lymph nodes, radiation to the nodal area may not be needed. Read more…
1 -
Tukysa Plus Kadcyla Better Than Kadcyla Alone for Metastatic Breast Cancer
Dec 7, 2023
Adding Tukysa to Kadcyla improved outcomes for metastatic HER2-positive disease. Read more…
1 -
Can Certain Younger Post-Menopausal Women With Low-Risk Breast Cancer Skip Radiation?
Dec 6, 2023
Research suggests that some younger post-menopausal women may be able to skip radiation after lumpectomy, but there are important points to consider. Read more…
0 -
Experimental Inavolisib Seems Promising for Certain Metastatic Breast Cancers
Dec 7, 2023
If approved, the medicine may be an alternative to Piqray for treating certain cancers with a PIK3CA mutation. Read more…
0 -
False-Positive Mammogram Result May Signal Higher Breast Cancer Risk
Dec 11, 2023
Women with a false-positive mammogram result had a 61% higher risk of breast cancer in the next 20 years. Read more…
0 -
What Improves Sexual Well-Being After Breast Cancer? Many Women Say Self-Help
Dec 11, 2023
When it comes to sexual functioning, many women with a history of breast cancer help themselves. Read more…
0 -
Pregnancy Safe After Breast Cancer in Young Women With BRCA Mutation
Dec 13, 2023
Having a child is safe for both mother and baby if women with a BRCA mutation get pregnant after a breast cancer diagnosis. Read more…
0 -
Regular Screening Mammograms Save Lives
Dec 14, 2023
Regular mammograms reduce the risk of dying from breast cancer by more than 65%. Read more…
0 -
Kadcyla Continues to Improve Survival in HER2-Positive Early-Stage Breast Cancer
Dec 17, 2023
More than eight years of follow-up from the KATHERINE trial showed the continued survival benefits of Kadcyla over Herceptin for HER2-positive breast cancer with a high risk of recurrence. Read more…
0 -
ASTRO Updates Partial-Breast Radiation Guidelines
Jan 11, 2024
New guidelines strongly recommend partial-breast radiation after lumpectomy for many small, early-stage breast cancers with no lymph node involvement. Read more…
0 -
Low Vitamin D Levels Up Risk of Chemotherapy-Induced Neuropathy
Jan 11, 2024
Low vitamin D levels increase the risk of neuropathy from chemotherapy. Read more…
0 -
Lymph Node Removal, Excess Weight Linked to Long-Term Arm Problems After Breast Cancer Treatment
Jan 11, 2024
Having underarm lymph nodes removed and having obesity seem to be the top two risk factors for arm issues that can last for years after breast cancer treatment is completed. Read more…
0 -
Exercise Lowers Breast Cancer Risk in Younger Women
Jan 12, 2024
Does just thinking about exercise make you tired? Consider this: Younger women who are more active have a lower risk of developing breast cancer. Read more…
0 -
Breast Self-Exam, Mammogram Best for Finding Invasive Breast Cancer After DCIS
Jan 15, 2024
After DCIS treatment, women who develop invasive breast cancer have the cancer found most often via mammogram or find it themselves, rather than during a doctor’s exam. Read more…
0 -
Soy Compounds May Reduce Breast Cancer Recurrence Risk
Feb 1, 2024
Natural compounds found in soy might reduce the risk of breast cancer recurrence. Read more…
0 -
U.S. Breast Cancer Deaths Drop Due to New Treatments, Screening
Mar 1, 2024
Breast cancer death rates in the United States dropped by nearly 60% between 1975 and 2019. Read more…
0 -
DCIS Diagnosed Outside Regular Screening Increases Invasive Disease Risk by 400%
Mar 7, 2024
If DCIS is found before regular mammograms start or in between regular screening, it more than quadruples the risk of invasive breast cancer. Read more…
0 -
Ovary Removal, MRI Screening for Breast Cancer Saves Lives in Women With BRCA Mutation
Mar 18, 2024
Women with a BRCA1 or BRCA2 mutation have a higher-than-average risk of breast and ovarian cancer. Two preventive strategies may reduce the risk of death among women with these mutations. Read more…
0 -
ASCO and SSO Update Genetic Testing Guidelines for People With Breast Cancer
Apr 8, 2024
Updated guidelines say anyone age 65 or younger diagnosed with breast cancer should have genetic testing for BRCA1 and BRCA2 mutations. Read more…
0 -
Apr 8, 2024
After chemotherapy before surgery for triple-negative breast cancer, Black women are less likely and Hispanic women are more likely than white women to have a pathologic complete response. Read more…
0 -
Risk of Death Lasts for 20 Years in Men With Early-Stage, Hormone Receptor-Positive Breast Cancer
Apr 10, 2024
Men with early-stage, hormone receptor-positive breast cancer have a fairly high risk of dying from breast cancer, even 20 years after diagnosis. Read more…
0
